Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2CNS 2Breast 2Thoracic 1

Conditions

Brain Neoplasms 133Glioblastoma 92Astrocytoma 44Neuroblastoma 40Glioma 40Central Nervous System Neoplasms 38Neoplasms 26Breast Neoplasms 25Neoplasm Metastasis 24Oligodendroglioma 20Gliosarcoma 19Carcinoma, Non-Small-Cell Lung 18Lymphoma, Follicular 14Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Medulloblastoma 13Burkitt Lymphoma 13Testicular Neoplasms 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Non-Hodgkin 12Lymphoma, Mantle-Cell 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Leukemia, Lymphocytic, Chronic, B-Cell 12Hodgkin Disease 12Sezary Syndrome 11Primary Myelofibrosis 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11

Interventions

motexafin gadolinium 1Lomustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × CNS × Clear all
NCT07100730 2026-04-16

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting
50 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT00054795 2007-05-08

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Pharmacyclics LLC.

Phase 3 Completed
550 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡